Tearsheet

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow


0 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -20%
Weak multi-year price returns
2Y Excs Rtn is -48%, 3Y Excs Rtn is -116%
Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -0.8 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -1.4%
1 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 2150%
  Expensive valuation multiples
P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 45x, P/EPrice/Earnings or Price/(Net Income) is 71x
2 Low stock price volatility
Vol 12M is 43%
  Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.8%
3 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Health & Wellness Trends. Themes include Geriatric Care, Preventative Healthcare, Show more.
  Key risks
JYNT key risks include [1] a history of financial restatements and material weaknesses in internal controls and [2] decelerating growth fueled by marketing inefficiency and high SG&A expenses.
0 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -20%
1 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 2150%
2 Low stock price volatility
Vol 12M is 43%
3 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Health & Wellness Trends. Themes include Geriatric Care, Preventative Healthcare, Show more.
4 Weak multi-year price returns
2Y Excs Rtn is -48%, 3Y Excs Rtn is -116%
5 Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -0.8 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -1.4%
6 Expensive valuation multiples
P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 45x, P/EPrice/Earnings or Price/(Net Income) is 71x
7 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.8%
8 Key risks
JYNT key risks include [1] a history of financial restatements and material weaknesses in internal controls and [2] decelerating growth fueled by marketing inefficiency and high SG&A expenses.

Valuation, Metrics & Events

JYNT Stock


Why The Stock Moved


Qualitative Assessment

AI Generated Analysis | Feedback



1. The Joint Corp. announced on July 30, 2025, its expectation to restate full year 2024 and first quarter 2025 financial statements due to overestimated non-cash impairment charges, creating uncertainty for investors at the start of the period.

2. The company revised its 2025 guidance downwards during its Q2 2025 earnings report on August 7, 2025, with system-wide sales expected to range from $530 million to $550 million, down from prior guidance of $550 million to $570 million.

Show more

Stock Movement Drivers

Return vs. Risk


Price Returns Compared

 202020212022202320242025Total [1]
Returns
JYNT Return63%150%-79%-31%11%-17%-45%
Peers Return-31%-9%23%-10%
S&P 500 Return16%27%-19%24%23%16%112%

Monthly Win Rates [3]
JYNT Win Rate67%58%25%33%58%58% 
Peers Win Rate53%38%40%55%42% 
S&P 500 Win Rate58%75%42%67%75%73% 

Max Drawdowns [4]
JYNT Max Drawdown-50%0%-80%-47%-7%-28% 
Peers Max Drawdown-43%-29%-17%-25% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 


[1] Cumulative total returns since the beginning of 2020
[2] Peers: USPH, SEM, PLNT, LTH, XWEL. See JYNT Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/19/2025 (YTD)

How Low Can It Go

Unique KeyEventJYNTS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-93.1%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven1355.9%34.1%
2022 Inflation ShockTime to BreakevenTime to BreakevenNot Fully Recovered days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-52.9%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven112.5%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven149 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-31.5%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven45.9%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven162 days120 days

Compare to MGRC, CRAI, III, TBI, PARK


In The Past

Joint's stock fell -93.1% during the 2022 Inflation Shock from a high on 9/3/2021. A -93.1% loss requires a 1355.9% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Joint (JYNT)

Better Bets than Joint (JYNT)

Trade Ideas

Select past ideas related to JYNT. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
17.4%17.4%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-6.7%-6.7%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
10.9%10.9%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
2.7%2.7%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
11.4%11.4%-5.1%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
17.4%17.4%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-6.7%-6.7%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
10.9%10.9%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
2.7%2.7%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
11.4%11.4%-5.1%

Recent Active Movers

Recent Active Movers

More From Trefis

Peer Comparisons for Joint

Peers to compare with:

Financials

JYNTUSPHSEMPLNTLTHXWELMedian
NameJoint US Physi.Select M.Planet F.Life TimeXWELL  
Mkt Price9.0077.8615.01111.3826.440.6620.73
Mkt Cap0.11.21.89.35.80.01.5
Rev LTM547595,3691,2882,913301,024
Op Inc LTM-175293378439-10184
FCF LTM25717420371-1564
FCF 3Y Avg665239198-82-1736
CFO LTM370408358794-12214
CFO 3Y Avg975465344581-14210

Growth & Margins

JYNTUSPHSEMPLNTLTHXWELMedian
NameJoint US Physi.Select M.Planet F.Life TimeXWELL  
Rev Chg LTM2,150.3%17.5%45.3%14.4%15.8%-12.7%16.6%
Rev Chg 3Y Avg689.7%11.9%-0.6%15.7%19.5%-20.7%13.8%
Rev Chg Q5.7%17.3%7.2%13.0%12.9%-12.8%10.1%
QoQ Delta Rev Chg LTM1.4%4.0%1.7%3.0%3.2%-3.5%2.4%
Op Mgn LTM-1.4%9.9%5.5%29.4%15.1%-33.9%7.7%
Op Mgn 3Y Avg-10.6%4.3%27.1%12.7%-48.4%10.6%
QoQ Delta Op Mgn LTM1.2%0.2%0.2%1.2%1.0%13.0%1.1%
CFO/Rev LTM5.6%9.2%7.6%27.8%27.2%-41.1%8.4%
CFO/Rev 3Y Avg-11.4%10.5%29.8%22.6%-45.9%11.4%
FCF/Rev LTM3.0%7.5%3.2%15.7%2.4%-51.2%3.1%
FCF/Rev 3Y Avg-9.9%5.6%17.1%-4.1%-53.8%5.6%

Valuation

JYNTUSPHSEMPLNTLTHXWELMedian
NameJoint US Physi.Select M.Planet F.Life TimeXWELL  
Mkt Cap0.11.21.89.35.80.01.5
P/S2.51.60.37.22.00.11.8
P/EBIT-177.513.15.623.013.3-0.39.3
P/E71.435.816.445.220.2-0.228.0
P/CFO45.017.04.425.97.3-0.312.2
Total Yield1.4%3.9%8.3%2.2%4.9%-402.5%3.1%
Dividend Yield0.0%1.1%2.2%0.0%0.0%0.0%0.0%
FCF Yield 3Y Avg4.4%4.9%8.5%3.3%-3.1%-216.6%3.9%
D/E0.00.31.50.30.72.50.5
Net D/E-0.20.21.50.20.71.40.5

Returns

JYNTUSPHSEMPLNTLTHXWELMedian
NameJoint US Physi.Select M.Planet F.Life TimeXWELL  
1M Rtn9.8%13.8%15.5%6.1%5.5%-13.6%7.9%
3M Rtn-9.6%-0.2%22.1%10.3%-5.0%-41.5%-2.6%
6M Rtn-21.9%6.0%2.1%3.9%-6.8%-31.0%-2.3%
12M Rtn-12.4%-12.7%-19.9%12.2%18.5%-59.1%-12.5%
3Y Rtn-39.9%-0.3%13.6%41.8%113.9%-91.7%6.6%
1M Excs Rtn5.5%11.6%14.3%4.1%3.6%-25.8%4.8%
3M Excs Rtn-15.2%-4.0%16.9%7.3%-8.7%-44.1%-6.4%
6M Excs Rtn-32.1%-9.3%-11.6%-11.1%-24.0%-44.1%-17.8%
12M Excs Rtn-30.9%-29.0%-33.1%-3.6%0.0%-76.4%-30.0%
3Y Excs Rtn-115.6%-76.1%-55.0%-28.3%29.8%-164.2%-65.5%

Financials

Segment Financials

Revenue by Segment

$ Mil20242023202220212020
Franchise operations52    
Total52    


Net Income by Segment
$ Mil20242023202220212020
Franchise operations-6    
Total-6    


Price Behavior

Short Interest

Short Interest: As Of Date11282025
Short Interest: Shares Quantity694,965
Short Interest: % Change Since 111520258.1%
Average Daily Volume154,602
Days-to-Cover Short Interest4.50
Basic Shares Quantity15,344,844
Short % of Basic Shares4.5%

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
11/6/2025-3.9%3.5%9.3%
7/30/2025-4.0%-3.2%-7.2%
5/8/2025-5.1%-4.0%13.2%
1/16/20251.7%2.6%4.8%
11/7/2024-2.3%-5.6%-2.9%
8/8/2024-8.4%-5.7%-10.2%
3/7/202430.0%29.1%41.2%
11/9/202312.9%12.8%29.9%
...
SUMMARY STATS   
# Positive101010
# Negative101010
Median Positive5.2%10.6%15.7%
Median Negative-4.6%-5.6%-20.3%
Max Positive30.0%29.1%41.2%
Max Negative-37.9%-40.0%-41.8%

SEC Filings

Expand for More

Report DateFiling DateFiling
93020251107202510-Q 9/30/2025
6302025812202510-Q 6/30/2025
3312025509202510-Q 3/31/2025
12312024314202510-K 12/31/2024
93020241108202410-Q 9/30/2024
6302024809202410-Q 6/30/2024
3312024503202410-Q 3/31/2024
12312023308202410-K 12/31/2023
93020231113202310-Q 9/30/2023
6302023926202310-Q 6/30/2023
3312023505202310-Q 3/31/2023
12312022310202310-K 12/31/2022
93020221104202210-Q 9/30/2022
6302022805202210-Q 6/30/2022
3312022506202210-Q 3/31/2022
12312021314202210-K 12/31/2021